Feature Channels:

Immunology

Add to Favorites Subscribe Share
fbshare-Immunology
Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1550
Embargo will expire:
18-Feb-2019 12:05 AM EST
Released to reporters:
17-Feb-2019 12:05 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Feb-2019 12:05 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

  • Embargo expired:
    16-Feb-2019 5:10 PM EST

Article ID: 708091

Drug combination may become new standard treatment for advanced kidney cancer

Dana-Farber Cancer Institute

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

Released:
15-Feb-2019 2:05 PM EST
CUIMC_RGB.jpg

Article ID: 708176

Why Some Brain Tumors Respond to Immunotherapy

Columbia University Irving Medical Center

Fewer than 1 in 10 patients with glioblastoma—the most common type of brain cancer—respond to immunotherapy; a new study reveals how to detect patients who may respond.

Released:
15-Feb-2019 11:05 AM EST
MSU-Wordmark-Green-120-pxls.gif

Article ID: 708137

This Immune Cell Function Could Control Deadly Allergic Reactions

Michigan State University

Michigan State University scientists have identified a master control mechanism on mast cells, a type of immune cell, that can prevent the immune system from overreacting in times of stress, potentially limiting, or even stopping allergic reactions from happening.

Released:
14-Feb-2019 4:05 PM EST
PennMed_logo.png

Article ID: 708133

Immune Profiling: A New Opportunity for Drug Development

Perelman School of Medicine at the University of Pennsylvania

Collectively, assessing a snapshot of a person’s unique state of immune health is called immune profiling, which can entail identifying immune-cell-associated genes and proteins, as well as the cell types themselves.

Released:
14-Feb-2019 3:05 PM EST
logoMOFFITT_2c_RGB.jpg

Article ID: 708090

Moffitt Researchers Characterize Mechanism of Action of CAR T Cells

Moffitt Cancer Center

Despite progress being made, scientists have not been completely certain of how CAR T cells function mechanistically. A team of Moffitt Cancer Center researchers addressed this uncertainty and characterized the mechanism of action of these new agents in a new article published this week in Science Signaling.

Released:
14-Feb-2019 9:00 AM EST
DamianMurray.jpg

Article ID: 708070

New Study Analyzes How Falling in Love Influences the Immune System in Women

Tulane University

As Valentine’s Day arrives, there’s no doubt love is once again in the air during this annual holiday that dates as far back as the 14th century. So, what exactly does it feel like to fall in love and how does love affect us as humans? Many scientists have proven falling in love has its physical benefits on both men and women, but can falling in love influence the immune system in women?

Released:
13-Feb-2019 4:05 PM EST
Crowe_2019-02-11_08-29-471.JPG
  • Embargo expired:
    13-Feb-2019 1:00 PM EST

Article ID: 708033

Supercomputing Effort Reveals Antibody Secrets

Vanderbilt University Medical Center

Using sophisticated gene sequencing and computing techniques, researchers at Vanderbilt University Medical Center (VUMC) and the San Diego Supercomputer Center have achieved a first-of-its-kind glimpse into how the body’s immune system gears up to fight off infection.

Released:
13-Feb-2019 11:00 AM EST
Embargo will expire:
19-Feb-2019 4:00 AM EST
Released to reporters:
13-Feb-2019 11:05 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Feb-2019 4:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

2-13-2019LarryCoverArtCAN181127_a.jpg

Article ID: 708013

Noninvasive Liquid Biopsies Rapidly, Accurately Determine Response to Cancer Treatment

Johns Hopkins Medicine

Results of two clinical studies have added to evidence that blood-based liquid biopsies can accurately track lung cancer treatment responses by measuring circulating tumor DNA (ctDNA) during immunotherapy and related treatments.

Released:
13-Feb-2019 10:00 AM EST

Showing results

110 of 1550

Chat now!